Sponsored By

Diabetes References 35667Diabetes References

December 5, 2005

5 Min Read
Diabetes References

12_05 Natural Products INSIDER
"Diabetes" cover story references:

1. Centers for Disease Control and Prevention. National diabetes fact sheet:general information and national estimates on diabetes in the United States,2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers forDisease Control and Prevention, 2005.

2. Ibid.

3. Ibid.

4. Ibid.

5. Ibid.

6. Ibid.

7. Ibid.

8. Ibid.

9. Ibid.

10. Ibid.

11. Ibid.

12. Ibid.

13. Ibid.

14. Ibid.

15. Ibid.

16. Ibid.

17. Ibid.

18. Ibid.

19. Ibid.

20. Ibid.

21. Ibid.

22. Barringer TA et al. " Effect of a Multivitamin and MineralSupplement on Infection and Quality of Life." Annals of InternalMedicine.138, 5:365-71, 2003. www.annals.org

23. Centers for Disease Control and Prevention. National diabetes fact sheet:general information and national estimates on diabetes in the United States,2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers forDisease Control and Prevention, 2005.

24. Wu T et al. "Fructose, glycemic load, and quantity and quality ofcarbohydrate in relation to plasma C-peptide concentrations in U.S. women."American Journal of Clinical Nutrition. 80, 4:1043-49, 2004. www.ajcn.org

25. Montonen J et al. " Whole-grain and fiber intake and the incidenceof type 2 diabetes." American Journal of Clinical Nutrition. 77,3:622-9, 2003. www.ajcn.org

26. Saltzman E et al. "An oat-containing hypocaloric diet reducessystolic blood pressure and improves lipid profile beyond effects of weight lossin men and women." Journal of Nutrition. 131, 5:1465-70, 2001. www.nutrition.org

27. Pins JJ et al. "Do whole-grain oat cereals reduce the need forantihypertensive medications and improve blood pressure control?" J FamPract. 51, 4:353-9, 2002. www.jfponline.com

28. Tapola N et al. " Glycemic responses of oat bran products in type 2diabetic patients." Nutrition, Metabolism and Cardiovascular Diseases.15, 4:255-261, 2005. www.sciencedirect.com

29. Jenkins AL et al. "Depression of the glycemic index by high levelsof beta-glucan fiber in two functional foods tested in type 2 diabetes." EuropeanJournal of Clinical Nutrition. 56, 7:622-8, 2002. www.nature.com

30. Proprietary study. Property of Cargill. 2005.

31. Proprietary study. Property of Cargill. 2005.

32. Proprietary study. Property of Cargill. 2005.

33. Takeo E et al. "Sweet elements of Siraitia grosvenori inhibitoxidative modification of low-density lipoprotein." Journal ofAtherosclerosis and Thrombosis. 9, 2:114-20, 2002. www.jstage.jst.go.jp

34. Gregersen S et al. "Antihyperglycemic effects of stevioside in Type2 diabetic subjects. Metabolism. 53, 1:73-6, 2004. www.journals.elsevierhealth.com

35. Jeppesen PB et al. Antihyperglycemic and blood pressure-reducingeffects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism.52, 3:372-8, 2003.

36. Sharafetdinov KhKh et al. "[Use of a new sugar substitute,erithritol, in the diet therapy of type 2 diabetes patients]." VoprPitan. 71, 3:19-23, 2002.

37. Yokozawa T et al. "Erythritol attenuates the diabetic oxidativestress through modulating glucose metabolism and lipid peroxidation instreptozotocin-induced diabetic rats." Journal of Agricultural and FoodChemistry. 50, 19:5485-89, 2002. http://pubs.acs.org/journals/jafcau/

38. Wang ZQ et al. "Effect of chromium picolinate on AMP-activatedprotein kinase alpha subunits and acetyl coenzyme A carboxylase in primarycultured human skeletal muscle cells. Abstract 24, A11. Presented at EuropeanAssociation for the Study of Diabetes annual meeting, 2005.

39. Ghosh D et al. "Role of chromium supplementation in Indians withtype 2 diabetes mellitus." The Journal of Nutritional Biochemistry.13:690-97, 2002.

40. Anderson RA et al. "Elevated intakes of supplemental chromiumimprove glucose and insulin variables in individuals with type 2 diabetes."Diabetes. 46, 11:1786-91, 1997. http://diabetes.diabetesjournals.org/

41. Komorowski JR et al. "Effect of chromium picolinate and biotincombination as an adjunctive nutritional therapy in poorly-controlled patientswith diabetes mellitus." Abstract 749, PS 61 Nutrition and Diet II..Presented at European Association for the Study of Diabetes annual meeting,2005.

42. Komorowski JR et al. "Chromium picolinate with biotin attenuateselevation in blood glucose levels in people with type II diabetes ingestionmedium carbohydrate beverages." Abstract 73, 580. Presented at AmericanCollege of Nutrition Annual Meeting, 2001.

43. Albarracin C et al. "Effect of chromium picolinate and biotincombination on coronary risk lipids and lipoproteins in subjects with non HDL -C(≥300 mg/dl) in type II diabetes mellitus." Presented at AmericanHeart Association ATVB, 2005.

44. Preuss HG et al. "Long-term effects of chromium, grape seed extractand zinc on various metabolic parameters of rats." Mol Cell Biochem.223, 1-2:95-102, 2001. www.wkap.nl

45. Bagchi M et al. "Efficacy and Toxicological Assessment of a Novel,Niacin-Bound Chromium in Ameliorating Metabolic Disorders." 10thInternational Congress of Toxicology-Finland 197:abs. 354, July 2004.

46. Wang JL et al. "Magnesium status and association with diabetes inthe Taiwanese elderly." Asia Pacific Journal of Clinical Nutrition.;14,3:263-9, 2005. www.ingentaconnect.com

47. Fung TT et al. "The Association between Magnesium Intake and FastingInsulin Concentration in Healthy Middle-Aged Women." Journal of theAmerican College of Nutrition. 22, 6:533-8, 2003. www.jacn.org

48. Cohen N et al. "Oral vanadyl sulfate improves hepatic and peripheralinsulin sensitivity in patients with non-insulin-dependent diabetesmellitus." Journal of Clinical Investigation. 95, 6:2501-9, 1995. www.jci.org

49. Hodgson G et al. "Coenzyme Q10 improves blood pressure and glycemiccontrol: a controlled trial in subjects with type 2 diabetes." EuropeanJournal of Clinical Nutrition. 56, 11:1137-42, 2002. www.nature.com

50. Watts GF et al. "Coenzyme Q(10) improves endothelial dysfunction ofthe brachial artery in Type II diabetes mellitus." Diabetologia. 45,3:420-6, 2002.

51. Ametov AS et al. "The sensory symptoms of diabetic polyneuropathyare improved with alpha-lipoic acid: the SYDNEY trial." Diabetes Care.26, 3:770-6, 2003. http://care.diabetesjournals.org/

52. Morcos M et al. "Effect of alpha-lipoic acid on the progression ofendothelial cell damage and albuminuria in patients with diabetes mellitus: anexploratory study." Diabetes Research and Clinical Practice. 52,3:175-83, 2001.

53. Khan A et al. "Cinnamon improves glucose and lipids of people withtype II diabetes." Diabetes Care. 26, 12: 3215-8, 2003. http://care.diabetesjournals.org/

54. Proprietary study. Property of Integrity. 2005.

55. Proprietary study. Property of Acatris. 2005.

56. Bunyapraphatsara N et al. "Antidiabetic activity of Aloe vera L.juice II. Clinical trial in diabetes mellitus patients in combination withglibenclamide." Phytomedicine. 3, 3:245-248, 1996. www.sciencedirect.com

57. Baskaran K et al. "Antidiabetic effect of a leaf extract fromGymnema sylvestre in non-insulin-dependent diabetes mellitus patients." Journalof Ethnopharmacology. 30, 3:295-300, 1990.

58. Ahmad N et al. "Effect of Momordica charantia (Karolla) extracts onfasting and postprandial serum glucose levels in NIDDM patients."Bangladesh Medical Research Council Bulletin. 25, 1:11-3, 1999.

59. Bates SH et al. "The Insulin-like Effect of Pinitol." BritishJournal of Pharmacology 130:1944-48, 2000.

60. Kim JI et al. "Effects of pinitol isolated from soybeans on glycemiccontrol and cardiovascular risk factors in Korean patients with type II diabetesmellitus: a randomized controlled study." European Journal of ClinicalNutrition. 59, 3:456-8, 2005. www.nature.com

61. Liu X et al. "Antidiabetic effect of Pycnogenol French maritime pinebark extract in patients with diabetes type II." Life Sciences. 75,21:2505-13, 2004. www.elsevier.com

62. Spadea L et al. "Treatment of vascular retinopathies withPycnogenol." Phytotherapy Research. 15, 3:219-23, 2001. www3.interscience.wiley.com

63. Horio H et al. "Maitake (Grifola frondosa) improve glucose toleranceof experimental diabetic rats." Journal of Nutritional Science andVitaminology. 47, 1:57-63, 2001.

64. Kubo K et al. "Anti-diabetic activity present in the fruit body ofGrifola frondosa (Maitake). I." Biological & Pharmaceutical Bulletin.17, 8:1106-10, 1994.

Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ members. Yes, it's completely free.

You May Also Like